Marshall Wace’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-68,493
| Closed | -$320K | – | 3831 |
|
|
2021
Q4 | $320K | Sell |
68,493
-118,940
| -63% | -$556K | ﹤0.01% | 2343 |
|
|
2021
Q3 | $1.6M | Buy |
+187,433
| New | +$1.6M | 0.01% | 1334 |
|
|
2021
Q2 | – | Sell |
-22,211
| Closed | -$491K | – | 2826 |
|
|
2021
Q1 | $491K | Buy |
22,211
+1,707
| +8% | +$37.7K | ﹤0.01% | 1652 |
|
|
2020
Q4 | $634K | Buy |
+20,504
| New | +$634K | ﹤0.01% | 1249 |
|